Ignite Creation Date:
2025-12-24 @ 11:16 PM
Ignite Modification Date:
2026-01-01 @ 9:29 PM
Study NCT ID:
NCT06991556
Status:
RECRUITING
Last Update Posted:
2025-12-08
First Post:
2025-05-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-07-07
Start Date Type:
ACTUAL
Primary Completion Date:
2032-04-19
Primary Completion Date Type:
ESTIMATED
Completion Date:
2035-11-07
Completion Date Type:
ESTIMATED
First Submit Date:
2025-05-08
First Submit QC Date:
None
Study First Post Date:
2025-05-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-05
Last Update Post Date:
2025-12-08
Last Update Post Date Type:
ESTIMATED